VCM
IDYA icon

Versant Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Versant Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Buy
2,825
+596
+27% +$18.2K 0.01% 897
2026
Q1 		$74.3K Hold
2,229
– – 0.01% 1017
2025
Q4 		$77.1K Hold
2,229
– – 0.01% 873
2025
Q3 		$60.7K Buy
2,229
+168
+8% +$4.06K 0.01% 942
2025
Q2 		$43.3K Buy
2,061
+1,495
+264% +$28.7K 0.01% 1057
2025
Q1 		$9.27K Buy
+566
New +$12.1K ﹤0.01% 1757

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Versant Capital Management's IDYA Position: Q2 2026 in Review

Versant Capital Management increased its IDEAYA Biosciences (IDYA) stake by 27% in Q2 2026, buying an estimated $18.2K and bringing the position to 2,825 shares worth $105K. The position accounts for 0.01% of the portfolio, ranked #897.

Versant Capital Management first reported a position in IDYA in Q1 2025 and has held it in 6 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Versant Capital Management held 2,825 shares of IDEAYA Biosciences worth $105K as of Q2 2026.
  • Versant Capital Management bought 596 IDEAYA Biosciences shares in Q2 2026, an estimated $18.2K.
  • IDEAYA Biosciences made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #897 holding.
  • Versant Capital Management first reported a position in IDEAYA Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.